Literature DB >> 8744548

Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.

C E Hormaeche1, P Mastroeni, J A Harrison, R Demarco de Hormaeche, S Svenson, B A Stocker.   

Abstract

The role of the main LPS O antigen in the specificity of protection as mediated by systemic mechanisms following immunization with live attenuated Aro Salmonella vaccines was studied in mice. Innately Salmonella-susceptible (Itys) BALB/c mice were immunized intravenously with a single dose of either Salmonella typhimurium SL3261 aroA (LPS O4,5,12) or Salmonella enteritidis Se795aroA (LPS O1,9,12), and challenged orally 2-3 months later with either S. typhimurium C5 or S. enteritidis Thirsk. Nearly isogenic transductants of the two challenge strains expressing either their own LPS or that of the other serotype (S. typhimurium C5 O4 or O9, and S. enteritidis Thirsk O9 or O4) were also used. Both vaccines conferred similar high protection against the virulent strain of the homologous serotype expressing its own LPS. There was no protection against the heterologous serotype expressing its own LPS. However, when vaccinated mice were challenged with either the same serotype as the vaccine but expressing the heterologous LPS, or with the heterologous serotype expressing the LPS of the vaccine, protection was always lower than protection against the fully homologous serotype. Anti-smooth LPS antibodies showed higher titres against the homologous LPS, but with significant crossreactivity with the heterologous LPS. Antibodies to O-rough S. typhimurium and S. enteritidis LPS were present following immunization with either of the two vaccine strains. The LPS alone cannot fully account for the specificity of protection in this model; other (protein) antigens may be responsible. It remains to be seen whether there is a T-cell mediated component to the specificity of protection conferred by live Salmonella vaccines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8744548     DOI: 10.1016/0264-410x(95)00249-z

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  31 in total

1.  Extracellular antigens from Salmonella enteritidis induce effective immune response in mice after oral vaccination.

Authors:  Lena Strindelius; Lena Degling Wikingsson; Ingvar Sjöholm
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

2.  Oral immunization with an rfaH mutant elicits protection against salmonellosis in mice.

Authors:  Gábor Nagy; Ulrich Dobrindt; Jörg Hacker; Levente Emödy
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

Review 3.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

4.  Enhanced virulence of Salmonella enterica serovar typhimurium after passage through mice.

Authors:  Pietro Mastroeni; Fiona J E Morgan; Trevelyan J McKinley; Ewan Shawcroft; Simon Clare; Duncan J Maskell; Andrew J Grant
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

Review 5.  Live attenuated vaccines for invasive Salmonella infections.

Authors:  Sharon M Tennant; Myron M Levine
Journal:  Vaccine       Date:  2015-04-19       Impact factor: 3.641

6.  Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity.

Authors:  Douglas M Heithoff; Elena Y Enioutina; Diana Bareyan; Raymond A Daynes; Michael J Mahan
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

Review 7.  Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.

Authors:  Raphael Simon; Sharon M Tennant; James E Galen; Myron M Levine
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

Review 8.  Antibodies and Protection in Systemic Salmonella Infections: Do We Still Have More Questions than Answers?

Authors:  Pietro Mastroeni; Omar Rossi
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

Review 9.  In vivo gene expression and the adaptive response: from pathogenesis to vaccines and antimicrobials.

Authors:  D M Heithoff; R L Sinsheimer; D A Low; M J Mahan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

10.  Salmonella DNA adenine methylase mutants confer cross-protective immunity.

Authors:  D M Heithoff; E Y Enioutina; R A Daynes; R L Sinsheimer; D A Low; M J Mahan
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.